Heritability in inflammatory bowel disease: From the first twin study to genome-wide association studies

Inflammatory Bowel Diseases

Volumn 21, Issue 6, 2015, Pages 1428-1434

  Gordon, Hannah ^a   Trier Moller, Frederik ^b,c,d   Andersen, Vibeke ^b,c   Harbord, Marcus ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Hospital of Southern Jutland   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

GWAS; Heritability; inflammatory bowel disease; missing heritability; twin studies

Indexed keywords

EPIGENETICS; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; REVIEW; SIBLING; TWINS; ENVIRONMENT; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TWIN STUDY;

ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATORY BOWEL DISEASES; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; TWIN STUDIES AS TOPIC;

EID: 84929884482     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000393     Document Type: Review

References (75)

1. Tysk C, Lindberg E, Järnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990-996.
2. Probert CSJ, Jayanthi V, Hughes AO, et al. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and South Asians in Leicestershire. Gut. 1993;34: 1547-1551.
3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.e42; quiz e30.
4. Kamm MA, De Cruz PP, Chan FK, et al. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266-1280.
5. Wray N, Visscher P. Estimating trait heritability. Nat Educ. 2008;1:29.
6. Franke A, McGovern DPB, Barrett JC, et al. Meta-analysis increases to 71 the tally of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
7. Spriggs EI. Chronic ulceration of the colon. Q J Med. 1934;27:549.
8. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133-144.
9. Halme L, Turunen U, Heliö T, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol. 2002;37: 692-698.
10. Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517-524.
11. Trier Moller F, Anderson V, Jess T. DOP021 Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011. JCC. 2014;8(Suppl 1):S24-S25.
12. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597-603.
13. Halme L, Paavola-Sakki P, Turunen U, et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol. 2006;12:3668-3672.
14. Satsangi J, Grootscholten C, Holt H, et al. Clinical patterns of familial inflammatory bowel disease. Gut. 1996;38:738-741.
15. Carbonnel F, Macaigne G, Beaugerie L, et al. Crohn's disease severity in familial and sporadic cases. Gut. 1999;44:91-95.
16. Rotter JI, Yang H, Shohat T. Genetic complexities of inflammatory bowel disease and its distribution among the Jewish people. In: Bonne-Tamir B, Adam A, eds. Genetic Diversity Among Jews: Disease and Markers at the DNA Level. Oxford, United Kingdom: Oxford University Press; 1992: 395-411.
17. Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940-1948.
18. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signalling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140-146.
19. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:1164-1176.
20. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361: 2033-2045.
21. Glocker EO, Frede N, Perro M, et al. Infant colitis-it's in the genes. Lancet. 2010;376:1272.
22. Lee CH, Hsu P, Nanan B, et al. Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease. J Crohns Colitis. 2014;8:1551-1556.
23. Megarbane A, Sayad R. Early lethal autosomal recessive enterocolitis: report of a second family. Clin Genet. 2007;71:89-90.
24. Fried K, Vure E. A lethal autosomal recessive entero-colitis of early infancy. Clin Genet. 1974;6:195-196.
25. Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol. 2004;18:525-539.
26. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84-88.
27. Orholm M, Binder V, Sorensen TI, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35:1075-1081.
28. Jess T, Riis L, Jespersgaard C, et al. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol. 2005;100: 2486-2492.
29. Spehlmann ME, Begun AZ, Burghardt J, et al. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008;14:968-976.
30. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767-1773.
31. Ng SC, Woodrow S, Patel N, et al. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:725-736.
32. van Dongen J, Slagboom PE, Draisma HH, et al. The continuing value of twin studies in the omics era. Nat Rev Genet. 2012;13:640-653.
33. Verweij KJ, Mosing MA, Zietsch BP, et al. Estimating heritability from twin studies. Methods Mol Biol. 2012;850:151-170.
34. Brand SR. Update on the heritability of Inflammatory Bowel Disease: the importance of twin studies. Inflamm Bowel Dis. 2011;17:1-5.
35. Bengtson MB, Aamodt G, Vatn MH, et al. Concordance for IBD among twins compared to ordinary siblings-a Nowegian population based study. J Crohns Colitis. 2010;4:312-318.
36. Jablon S, Neel JV, Gershowitz H, et al. The NAS-NRC twin panel: methods of construction of the panel, zygosity diagnosis, and proposed use. Am J Hum Genet. 1967;19:133-161.
37. Scheike TH, Holst KK, Hjelmborg JB. Estimating twin concordance for bivariate competing risks twin data. Stat Med. 2014;33:1193-1204.
38. Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet. 1966;29:51-76.
39. Reich T, James JW, Morris CA. The use of mutiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet. 1972;36:163-184.
40. Chen GB, Lee SH, Brion MJ, et al; International IBD Genetics Consortium. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet. 2014;23:4710-4720.
41. Benchek PH, Morris NJ. How meaningful are heritability estimates of liability? Hum Genet. 2013;132:1351-1360.
42. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11:2463-2468.
43. Visscher PM, Macgregora S, Benyamina B, et al. Genome partitioning of genetic variation for height from 11, 214 sibling pairs. Am J Med Genet. 2007;81:1104-1110.
44. Zhang F, Gu W, Hurles ME, et al. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009; 10:451-481.
45. Ehli EA, Abdellaoui A, Hu Y, et al. De novo and inherited CNVs in MZ twin pairs selected for discordance and concordance on attention problems. Eur J Hum Genet. 2012;11:1037-1043.
46. Castellani CA, Awamleh Z, Melka MG, et al. Copy number variation distribution in six monozygotic twin pairs discordant for schizophrenia. Twin Res Hum Genet. 2014;17:108-120.
47. Curran, Mark (2005). "Twinning." Focus Information Technology. Retrieved 2008-10-10.
48. McGue M, Bouchard TJ Jr. Genetic and environmental influences on human behavioural differences. Annu Rev Neurosci. 1998;21:1-24.
49. Richardson K, Norgate S. The equal environments assumption of classical twin studies may not hold. Br J Educ Psychol. 2005;75:339-350.
50. Derks EM, Dolan CV, Boomsma DI. A test of the equal environment assumption (EEA) in multivariate twin studies. Twin Res Hum Genet. 2006;9:403-411.
51. Lee SH, Wray NR, Goddard ME, et al. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011; 88:294-305.
52. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
53. Sullivan PF. The genetics of schizophrenia. PLoS Med. 2005;2:e212.
54. Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007;12:2-22.
55. Goddard ME, Wray NR, Verbyla K, et al. Estimating effects and making predictions from genome-wide marker data. Stat Sci. 2009;24:517-529.
56. Lee JC, Parkes M. Genome-wide association studies and Crohn's disease. Brief Funct Genomics. 2011;10:71-76.
57. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008;40:695-701.
58. Hunt KA, Mistry V, Bockett NA, et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature. 2013;498:232-235.
59. Wray N, Purcell S, Visscher P. Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol. 2011;9:e1000579.
60. Park JH, Wacholder S, Gail MH, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet. 2010;42:570-575.
61. Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet. 2010;42:565-569.
62. Gusev A, Bhatia G, Zaitlen N, et al. Quantifying missing heritability at known GWAS loci. PLoS Genet. 2013;9:e1003993.
63. Zuk O, Hechter E, Sunyaev SR, et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA. 2012;109:1193-1198.
64. Pierik M, Yang H, Barmada MM, et al. The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis. 2005;11:1-7.
65. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:339-346.
66. Nimmo ER, Prendergast JG, Aldhous MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis. 2012;18:889-899.
67. Wu F, Guo NJ, Tian H, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2011;17: 241-250.
68. Tsaprouni L, Ito K, Powell J, et al. Differential patterns of histone acetylation in inflammatory bowel diseases. J Inflamm (Lond). 2011;8:1.
69. Gevers D, Kugathasan S, Denson Lee A, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-392.
70. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268-1273.
71. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640.
72. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut. 1997;40:572-574.
73. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
74. An European consortium to boost our understanding of inflammatory bowel disease. Available at: www.ibdcharacter.eu/. Accessed December 12, 2014.
75. Crohn's and colitis Canada inflammatory bowel disease GEM project. Available at: www.gemproject.ca. Accessed December 20, 2014.